AGTPBP1 (gene)

Last updated
AGTPBP1
Identifiers
Aliases AGTPBP1 , CCP1, NNA1, ATP/GTP binding protein 1, CONDCA, ATP/GTP binding carboxypeptidase 1
External IDs OMIM: 606830 MGI: 2159437 HomoloGene: 9067 GeneCards: AGTPBP1
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001286715
NM_001286717
NM_015239
NM_001330701

RefSeq (protein)

NP_001273644
NP_001273646
NP_001317630
NP_056054
NP_056054.2

Contents

Location (UCSC) Chr 9: 85.55 – 85.74 Mb Chr 13: 59.59 – 59.73 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

ATP/GTP binding protein 1 is gene that encodes the protein known as cytosolic carboxypeptidase 1 (CCP1), originally named NNA1. Mice with a naturally occurring mutation of the Agtpbp1 gene are known as pcd mice (Purkinje cell degeneration). [5]

Several spontaneous Agtpbp1 alleles have been discovered in mice. [6] The autosomal recessive Purkinje cell degeneration mutation affects Agtpbp1 located on mouse chromosome 13, with alleles containing a zinc carboxypeptidase domain and an ATP/GTP binding motif, a protein first identified in alpha-motoneurons during axonal regeneration. [7] and destabilized in the mutation. [8]

In Agtpbp1-pcd mutant mice, the predominant pathology comprises near total Purkinje cell loss from the third to the fourth postnatal week along with a more slowly progressing loss in retinal photoreceptors. [9] The slower and less complete degeneration of inferior olive neurons is most probably a consequence of retrograde degeneration secondary to Purkinje cell loss. [10] and the degeneration of deep cerebellar nuclei a consequence of anterograde degeneration secondary to Purkinje cell loss. [11] [12]

Based on sequence similarities, CCP1 was proposed to be involved in tubulin processing along with five other carboxypeptidases, designated CCP2 to CCP6. [13] The abnormal development in Purkinje cell dendrites of Agtpbp1-pcd mice was linked to a decrease in microtubule-associated proteins 1B and 2. [14] Microtubule structure and dynamics can be seen to be impaired in embryonic fibroblasts of Agtpbp1-pcd mice. [15] In particular, Purkinje cell loss in Agtpbp1-pcd mice was linked with microtubule hyperglutamylation, [16] as with human subjects lacking Agtpbp1. [17]

In view of Purkinje cell loss, gamma-aminobutyric acid (GABA) concentrations decreased in the cerebellum of Agtpbp1-pcd mutants. [18] In particular, GABA concentrations decreased in the deep cerebellar nuclei, target of Purkinje axons, but not in cerebellar cortex despite Purkinje cell loss, presumably because the maintenance of inhibitory interneurons compensated for it in a shrunken cerebellum. [19] In line with the Purkinje cell loss, the number of GABAergic terminal boutons declined in deep cerebellar nuclei of Agtpbp1-pcd mutants. [20] while the density of GABAergic soma in the deep cerebellar nuclei was normal. [21] Presumably because of post-synaptic supersensitivity following Purkinje cell loss, binding of the GABA-A receptor and its associated benzodiazepine receptor (BZD) receptor increased in deep cerebellar nuclei of Agtpbp1-pcd mutants. [22] In particular, there was an increase in large aggregates of the GABA-A-alpha receptor subtype in deep cerebellar nuclei. [23]

Presumably because of slowly progressing granule cell deterioration., [24] glutamate concentrations per protein weight decreased in the cerebellar cortex of 6, 9, and 12 month-old Agtpbp1-pcd mutants (McBride and Ghetti, 1978). [25] On the contrary, their glutamate concentrations per tissue weight were equivalent to controls in cerebellar cortex and deep nuclei at younger ages of 1 to 3 months (Roffler-Tarlov et al., 1979), [26] presumably because of slowly progressing granule cell deterioration. [27] Non-NMDA receptor binding decreased in molecular and granule cell layers of the cerebellar cortex but not the deep nuclei of Agtpbp1-pcd mutants (Stasi et al., 1997). More particularly, the decline in binding occurred for the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA receptor) receptor at the level of molecular and granule cell layers. [28] The residual presence of AMPA receptors in the molecular layer despite Purkinje cell loss was attributed to the continued maintenance of stellate and basket cells.

Monoamine systems have been examined in view of cerebellar targets by 5-hydroxy-tryptamine (5HT) fibers originating from medial and dorsal raphe nuclei, noradrenaline fibers from the locus coeruleus, and dopamine fibers from the ventral tegmental area. 5HT concentrations increased in the cerebellum of Agtpbp1-pcd mutant mice, [29] as did 5HT fiber density. [30] and 5HT uptake binding. [31] The results are more variable when 5HT content per cerebellum is considered, increases being found only in older (9 and 15 months of age) not younger (3 and 6 months of age) mice. [32]

In a similar manner to the 5HT system, noradrenaline concentrations increased in Agtpbp1-pcd mutants. [33] [34] [35] [36] Noradrenaline uptake per protein weight increased in cerebellar cortex and deep nuclei of Agtpbp1-pcd mutants, but was unchanged when surface areas was taken into account. [37] Increases per protein weight were also discerned in the granule cell layer and deep nuclei for alpha-1-adrenergic receptor and alpha-2-adrenergic receptor binding as well as beta-adrenergic receptor binding in cerebellar cortex. With total area binding in cerebellar cortex, values were still higher than normal for alpha-2-adrenergic receptors but were lower than normal for the other two.

More limited data are available with the other major brain catecholamine, dopamine. Dopamine transporter binding increased in deep cerebellar nuclei but decreased in the cerebellar molecular layer of Agtpbp1-pcd mutants. [38]

Agtpbp1-pcd mutant mice display overt ataxia (widespread gait) together with irregularly spaced strides on foot-print analyses [39] and motor coordination deficits based on kinematic analyses of multijoint, interlimb, and whole-body movements, [40] more missteps, shorter steps, and longer step times in the Erasmus ladder task, [41] and latencies before falling from the rotarod performance test and other apparatus. [42] [43] The mutants also exhibit anomalies in exploratory activities, including spontaneous alternation. [44] [45] [46] In addition, Agtpbp1-pcd mice had slowed acquisition of spatial learning in the Morris water maze while swimming normally towards a visible platform relative to heterozygotes but not wild-type mice. [47] [48]

Function

CCP1/NNA1 is a zinc carboxypeptidase that contains nuclear localization signals that was initially cloned from regenerating spinal cord neurons of the mouse. Although originally thought to contain an ATP/GTP-binding motif, this was not experimentally verified, and the potential domain is not conserved through evolution.

[supplied by OMIM, Jul 2002].

Notes

Related Research Articles

Cerebellum Structure at the rear of the vertebrate brain, beneath the cerebrum

The cerebellum is a major feature of the hindbrain of all vertebrates. Although usually smaller than the cerebrum, in some animals such as the mormyrid fishes it may be as large as or even larger. In humans, the cerebellum plays an important role in motor control. It may also be involved in some cognitive functions such as attention and language as well as emotional control such as regulating fear and pleasure responses, but its movement-related functions are the most solidly established. The human cerebellum does not initiate movement, but contributes to coordination, precision, and accurate timing: it receives input from sensory systems of the spinal cord and from other parts of the brain, and integrates these inputs to fine-tune motor activity. Cerebellar damage produces disorders in fine movement, equilibrium, posture, and motor learning in humans.

In neurophysiology, long-term depression (LTD) is an activity-dependent reduction in the efficacy of neuronal synapses lasting hours or longer following a long patterned stimulus. LTD occurs in many areas of the CNS with varying mechanisms depending upon brain region and developmental progress.

Eyeblink conditioning (EBC) is a form of classical conditioning that has been used extensively to study neural structures and mechanisms that underlie learning and memory. The procedure is relatively simple and usually consists of pairing an auditory or visual stimulus with an eyeblink-eliciting unconditioned stimulus (US). Naïve organisms initially produce a reflexive, unconditioned response (UR) that follows US onset. After many CS-US pairings, an association is formed such that a learned blink, or conditioned response (CR), occurs and precedes US onset. The magnitude of learning is generally gauged by the percentage of all paired CS-US trials that result in a CR. Under optimal conditions, well-trained animals produce a high percentage of CRs. The conditions necessary for, and the physiological mechanisms that govern, eyeblink CR learning have been studied across many mammalian species, including mice, rats, guinea pigs, rabbits, ferrets, cats, and humans. Historically, rabbits have been the most popular research subjects.

Inferior olivary nucleus Brain structure in the medulla that helps coordinate movement

The inferior olivary nucleus (ION), is a structure found in the medulla oblongata underneath the superior olivary nucleus. In vertebrates, the ION is known to coordinate signals from the spinal cord to the cerebellum to regulate motor coordination and learning. These connections have been shown to be tightly associated, as degeneration of either the cerebellum or the ION results in degeneration of the other.

Purkinje cell Specialized neuron in the cerebellum

Purkinje cells, or Purkinje neurons, are a class of GABAergic inhibitory neurons located in the cerebellum. They are named after their discoverer, Czech anatomist Jan Evangelista Purkyně, who characterized the cells in 1839.

The zona incerta (ZI) is a horizontally elongated region of gray matter in the subthalamus below the thalamus. Its connections project extensively over the brain from the cerebral cortex down into the spinal cord.

Paraneoplastic cerebellar degeneration (PCD) is a paraneoplastic syndrome associated with a broad variety of tumors including lung cancer, ovarian cancer, breast cancer, Hodgkin’s lymphoma and others. PCD is a rare condition that occurs in less than 1% of cancer patients.

HERC1

Probable E3 ubiquitin-protein ligase HERC1 is an enzyme that in humans is encoded by the HERC1 gene.

GRID2 Protein-coding gene in the species Homo sapiens

Glutamate receptor, ionotropic, delta 2, also known as GluD2, GluRδ2, or δ2, is a protein that in humans is encoded by the GRID2 gene. This protein together with GluD1 belongs to the delta receptor subtype of ionotropic glutamate receptors. They possess 14–24% sequence homology with AMPA, kainate, and NMDA subunits, but, despite their name, do not actually bind glutamate or various other glutamate agonists.

Altanserin Chemical compound

Altanserin is a compound that binds to the 5-HT2A receptor. Labeled with the isotope fluorine-18 it is used as a radioligand in positron emission tomography (PET) studies of the brain, i.e., studies of the 5-HT2A neuroreceptors. Besides human neuroimaging studies altanserin has also been used in the study of rats.

Dentatorubral–pallidoluysian atrophy Congenital disorder of nervous system

Dentatorubral–pallidoluysian atrophy (DRPLA) is an autosomal dominant spinocerebellar degeneration caused by an expansion of a CAG repeat encoding a polyglutamine tract in the atrophin-1 protein. It is also known as Haw River Syndrome and Naito–Oyanagi disease. Although this condition was perhaps first described by Smith et al. in 1958, and several sporadic cases have been reported from Western countries, this disorder seems to be very rare except in Japan.

GABRD

Gamma-aminobutyric acid receptor subunit delta is a protein that in humans is encoded by the GABRD gene. In the mammalian brain, the delta (δ) subunit forms specific GABAA receptor subtypes by co-assembly leading to δ subunit containing GABAA receptors.

Axon terminal

Axon terminals are distal terminations of the telodendria (branches) of an axon. An axon, also called a nerve fiber, is a long, slender projection of a nerve cell, or neuron, that conducts electrical impulses called action potentials away from the neuron's cell body, or soma, in order to transmit those impulses to other neurons, muscle cells or glands.

Anatomy of the cerebellum Structures in the cerebellum, a part of the brain

The anatomy of the cerebellum can be viewed at three levels. At the level of gross anatomy, the cerebellum consists of a tightly folded and crumpled layer of cortex, with white matter underneath, several deep nuclei embedded in the white matter, and a fluid-filled ventricle in the middle. At the intermediate level, the cerebellum and its auxiliary structures can be broken down into several hundred or thousand independently functioning modules or compartments known as microzones. At the microscopic level, each module consists of the same small set of neuronal elements, laid out with a highly stereotyped geometry.

Dextrallorphan Chemical compound

Dextrallorphan (DXA) is an chemical of the morphinan class that is used in scientific research. It acts as a σ1 receptor agonist and NMDA receptor antagonist. It has no significant affinity for the σ2, μ-opioid, or δ-opioid receptor, or for the serotonin or norepinephrine transporter. As an NMDA receptor antagonist, in vivo, it is approximately twice as potent as dextromethorphan, and five-fold less potent than dextrorphan.

Granule cell Type of neuron with a very small cell body

The name granule cell has been used for a number of different types of neurons whose only common feature is that they all have very small cell bodies. Granule cells are found within the granular layer of the cerebellum, the dentate gyrus of the hippocampus, the superficial layer of the dorsal cochlear nucleus, the olfactory bulb, and the cerebral cortex.

Rhombic lip Posterior section of the developing metencephalon

The rhombic lip is a posterior section of the developing metencephalon which can be recognized transiently within the vertebrate embryo. It extends posteriorly from the roof of the fourth ventricle to dorsal neuroepithelial cells. The rhombic lip can be divided into eight structural units based on rhombomeres 1-8 (r1-r8), which can be recognized at early stages of hindbrain development. Producing granule cells and five brainstem nuclei, the rhombic lip plays an important role in developing a complex cerebellar neural system.

Unipolar brush cell

Unipolar brush cells (UBCs) are a class of excitatory glutamatergic interneuron found in the granular layer of the cerebellar cortex and also in the granule cell domain of the cochlear nucleus.

Spinocerebellar ataxia type 1 Rare neurodegenerative disorder

Spinocerebellar ataxia type 1 (SCA1) is a rare autosomal dominant disorder, which, like other spinocerebellar ataxias, is characterized by neurological symptoms including dysarthria, hypermetric saccades, and ataxia of gait and stance. This cerebellar dysfunction is progressive and permanent. First onset of symptoms is normally between 30 and 40 years of age, though juvenile onset can occur. Death typically occurs within 10 to 30 years from onset.

IPTBO Chemical compound

IPTBO is a bicyclic phosphate convulsant. It is an extremely potent GABA receptor antagonist that can cause violent convulsions in mice.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000135049 - Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000021557 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. "Entrez Gene: ATP/GTP binding protein 1" . Retrieved 2018-06-13.
  6. Fernandez-Gonzalez A, La Spada AR, Treadaway J, Higdon JC, Harris BS, Sidman RL, Morgan JI, Zuo J (2002). "Purkinje cell degeneration (pcd) phenotypes caused by mutations in the axotomy-induced gene, Nna1". Science. 295 (5561): 1904–6. Bibcode:2002Sci...295.1904F. doi:10.1126/science.1068912. PMID   11884758. S2CID   24520602.
  7. Harris A, Morgan JI, Pecot M, Soumare A, Osborne A, Soares HD (2000). "Regenerating motor neurons express Nna1, a novel ATP/GTP-binding protein related to zinc carboxypeptidases". Mol Cell Neurosci. 16 (5): 578–96. doi:10.1006/mcne.2000.0900. PMID   11083920. S2CID   32298322.
  8. Chakrabarti L, Neal JT, Miles M, Martinez RA, Smith AC, Sopher BL, La Spada AR (2006). "The Purkinje cell degeneration 5J mutation is a single amino acid insertion that destabilizes Nna1 protein". Mamm Genome. 17 (2): 103–110. doi:10.1007/s00335-005-0096-x. PMID   16465590. S2CID   19289988.
  9. Mullen RJ, Eicher EM, Sidman RL (1976). "Purkinje cell degeneration: a new neurological mutation in the mouse". Proc Natl Acad Sci USA. 73 (1): 208–12. Bibcode:1976PNAS...73..208M. doi: 10.1073/pnas.73.1.208 . PMC   335870 . PMID   1061118.
  10. Ghetti B, Norton, J, Triarhou, LC (1987). "Nerve cell atrophy and loss in the inferior olivary complex of 'Purkinje cell degeneration' mutant mice". J Comp Neurol. 260 (3): 409–22. doi:10.1002/cne.902600307. PMID   3597839. S2CID   37783783.
  11. Triarhou LC, Norton J, Ghetti B (1987). "Anterograde transsynaptic degeneration in the deep cerebellar nuclei of Purkinje cell degeneration (pcd) mutant mice". Exp Brain Res. 66 (3): 577–88. doi:10.1007/BF00270691. PMID   3609202. S2CID   2596179.
  12. Bäurle J, Grüsser-Cornehls U (1997). "Differential number of glycine- and GABA-immunopositive neurons and terminals in the deep cerebellar nuclei of normal and Purkinje cell degeneration mutant mice". J Comp Neurol. 382 (4): 443–458. doi:10.1002/(SICI)1096-9861(19970616)382:4<443::AID-CNE2>3.0.CO;2-2. PMID   9184992. S2CID   45413688.
  13. Kalinina E, Biswas R, Berezniuk I, Hermoso A, Aviles FX, Fricker LD (2007). "A novel subfamily of mouse cytosolic carboxypeptidases". FASEB J. 21 (3): 836–850. doi:10.1096/fj.06-7329com. PMID   17244818. S2CID   44806701.
  14. Li J, Gu X, Ma Y, Calicchio ML, Kong D, Teng YD, Yu L, Crain AM, Vartanian TK, Pasqualini R, Arap W, Libermann TA, Snyder EY, Sidman RL (2010). "Nna1 mediates Purkinje cell dendritic development via lysyl oxidase propeptide and NF-κB signaling". Neuron. 68 (1): 45–60. doi:10.1016/j.neuron.2010.08.013. PMC   4457472 . PMID   20920790.
  15. Munoz-Castaneda R, Díaz D, Peris L, Andrieux A, Bosc C, Munoz-Castañeda JM, Janke C, Alonso JR, Moutin MJ, Weruaga E (2018). "Cytoskeleton stability is essential for the integrity of the cerebellum and its motor- and affective-related behaviors". Sci Rep. 8 (1): 3072. Bibcode:2018NatSR...8.3072M. doi:10.1038/s41598-018-21470-2. PMC   5814431 . PMID   29449678.
  16. Rogowski K, van Dijk J, Magiera MM, Bosc C, Deloulme JC, Bosson A, Peris L, Gold ND, Lacroix B, Bosch Grau M, Bec N, Larroque C, Desagher S, Holzer M, Andrieux A, Moutin MJ, Janke C (2010). "A family of protein-deglutamylating enzymes associated with neurodegeneration" (PDF). Neurochem Res. 143 (4): 564–78. doi:10.1016/j.cell.2010.10.014. PMID   21074048. S2CID   17602571.
  17. Shashi V, Magiera MM, Klein D, Zaki M, Schoch K, Rudnik-Schöneborn S, Norman A, et al. (2018). "Loss of tubulin deglutamylase CCP1 causes infantile-onset neurodegeneration". EMBO J. 37 (23): e100540. doi:10.15252/embj.2018100540. PMC   6276871 . PMID   30420557.
  18. McBride WJ, Ghetti B (1988). "Changes in the content of glutamate and GABA in the cerebellar vermis and hemispheres of the Purkinje cell degeneration (pcd) mutant". Neurochem Res. 13 (2): 121–5. doi:10.1007/BF00973323. PMID   2896308. S2CID   20566736.
  19. Roffler-Tarlov S, Beart PM, O'Gorman S, Sidman RL (1979). "Neurochemical and morphological consequences of axon terminal degeneration in cerebellar deep nuclei of mice with inherited Purkinje cell degeneration". Brain Res. 168 (1): 75–95. doi:10.1016/0006-8993(79)90129-x. PMID   455087. S2CID   19618884.
  20. Wassef M, Simons J, Tappaz ML, Sotelo C (1986). "Non-Purkinje cell GABAergic innervation of the deep cerebellar nuclei: a quantitative immunocytochemical study in C57BL and in Purkinje cell degeneration mutant mice". Brain Res. 399 (1): 125–135. doi:10.1016/0006-8993(86)90606-2. PMID   3542126. S2CID   12720868.
  21. Bäurle J, Grüsser-Cornehls U (1997). "Differential number of glycine- and GABA-immunopositive neurons and terminals in the deep cerebellar nuclei of normal and Purkinje cell degeneration mutant mice". J Comp Neurol. 382 (4): 443–458. doi:10.1002/(SICI)1096-9861(19970616)382:4<443::AID-CNE2>3.0.CO;2-2. PMID   9184992. S2CID   45413688.
  22. Stasi K, Mitsacos A, Triarhou LC, Kouvelas ED (1997). "Cerebellar grafts partially reverse amino acid receptor changes observed in the cerebellum of mice with hereditary ataxia: quantitative autoradiographic studies". Cell Transplant. 6 (3): 347–59. doi:10.1016/s0963-6897(97)00036-5. PMID   9171167.
  23. Garin N, Hornung JP, Escher G (2002). "Distribution of postsynaptic GABA(A) receptor aggregates in the deep cerebellar nuclei of normal and mutant mice". J Comp Neurol. 447 (3): 210–7. doi:10.1002/cne.10226. PMID   11984816. S2CID   24088948.
  24. Triarhou LC (1998). "Rate of neuronal fallout in a transsynaptic cerebellar model". Brain Res Bull. 47 (3): 219–22. doi:10.1016/s0361-9230(98)00076-8. PMID   9865853. S2CID   33518155.
  25. McBride WJ, Ghetti B (1988). "Changes in the content of glutamate and GABA in the cerebellar vermis and hemispheres of the Purkinje cell degeneration (pcd) mutant". Neurochem Res. 13 (2): 121–5. doi:10.1007/BF00973323. PMID   2896308. S2CID   20566736.
  26. Roffler-Tarlov S, Beart PM, O'Gorman S, Sidman RL (1979). "Neurochemical and morphological consequences of axon terminal degeneration in cerebellar deep nuclei of mice with inherited Purkinje cell degeneration". Brain Res. 168 (1): 75–95. doi:10.1016/0006-8993(79)90129-x. PMID   455087. S2CID   19618884.
  27. Triarhou LC (1998). "Rate of neuronal fallout in a transsynaptic cerebellar model". Brain Res Bull. 47 (3): 219–22. doi:10.1016/s0361-9230(98)00076-8. PMID   9865853. S2CID   33518155.
  28. Fragioudaki K, Giompres P, Smith AL, Triarhou LC, Kouvelas ED, Mitsacos A (2002). "AMPA receptor subunit RNA transcripts and [(3)H]AMPA binding in the cerebellum of normal and pcd mutant mice: an in situ hybridization study combined with receptor autoradiography". J Neural Transm. 109 (9): 1115–27. doi:10.1007/s00702-001-0682-3. PMID   12203039. S2CID   22557348.
  29. Ohsugi K, Adachi K, Ando K (1986). "Serotonin metabolism in the CNS in cerebellar ataxic mice". Experientia. 42 (11–12): 1245–7. doi:10.1007/BF01946406. PMID   2430828. S2CID   1510598.
  30. Triarhou LC, Ghetti B (1991). "Serotonin-immunoreactivity in the cerebellum of two neurological mutant mice and the corresponding wild-type genetic stocks". J Chem Neuroanat. 4 (6): 421–8. doi:10.1016/0891-0618(91)90022-5. PMID   1781951. S2CID   13729250.
  31. Le Marec N, Hébert C, Amdiss F, Botez MI, Reader TA (1998). "Regional distribution of 5-HT transporters in the brain of wild type and 'Purkinje cell degeneration' mutant mice: a quantitative autoradiographic study with [3H]citalopram". J Chem Neuroanat. 15 (3): 155–71. doi:10.1016/s0891-0618(98)00041-6. PMID   9797073. S2CID   21369858.
  32. Ghetti B, Perry KW, Fuller RW (1988). "Serotonin concentration and turnover in cerebellum and other brain regions of pcd mutant mice". Brain Res. 458 (2): 367–71. doi:10.1016/0006-8993(88)90480-5. PMID   2463052. S2CID   36772221.
  33. Kostrzewa RM, Harston CT (1986). "Altered histofluorescent pattern of noradrenergic innervation of the cerebellum of the mutant mouse Purkinje cell degeneration". Neuroscience. 18 (4): 809–15. doi:10.1016/0306-4522(86)90101-6. PMID   3762927. S2CID   45209526.
  34. Ghetti B, Perry KW, Fuller RW (1987). "Norepinephrine metabolism in the cerebellum of the Purkinje cell degeneration (pcd) mutant mouse". Neurochem. Int. 10 (1): 39–47. doi:10.1016/0197-0186(87)90170-7. PMID   20501080. S2CID   19294786.
  35. Roffler-Tarlov S, Landis SC, Zigmond MJ (1984). "Effects of Purkinje cell degeneration on the noradrenergic projection to mouse cerebellar cortex". Brain Res. 298 (2): 303–11. doi:10.1016/0006-8993(84)91429-x. PMID   6144362. S2CID   43603541.
  36. Felten, DL, Felten, SY, Perry, KW, Fuller RW, Nurnberger JI, Ghetti B (1986). "Noradrenergic innervation of the cerebellar cortex in normal and in Purkinje cell degeneration mutant mice: evidence for long term survival following loss of the two major cerebellar cortical neuronal populations". Neuroscience. 18 (4): 783–93. doi:10.1016/0306-4522(86)90099-0. PMID   3762925. S2CID   21903927.
  37. Strazielle C, Lalonde R, Hébert N, Reader TA (1999). "Regional brain distribution of noradrenaline uptake sites, and of alpha1-alpha2- and beta-adrenergic receptors in PCD mutant mice: a quantitative autoradiographic study". Neuroscience. 80 (3): 343–6. doi:10.1016/s0306-4522(99)00321-8. PMID   10613519. S2CID   140206348.
  38. Delis F, Mitsacos A, Giompres P (2004). "Dopamine receptor and transporter levels are altered in the brain of Purkinje Cell Degeneration mutant mice". Neuroscience. 125 (1): 255–68. doi:10.1016/j.neuroscience.2004.01.020. PMID   15051164. S2CID   26876977.
  39. Wang T, Parris J, Li L, Morgan JI (2006). "The carboxypeptidase-like substrate-binding site in Nna1 is essential for the rescue of the Purkinje cell degeneration (pcd) phenotype". Mol Cell Neurosci. 33 (2): 200–13. doi:10.1016/j.mcn.2006.07.009. PMID   16952463. S2CID   20220682.
  40. Machado AS, Marques HG, Duarte DF, Darmohray DM, Carey MR (2020). "Shared and specific signatures of locomotor ataxia in mutant mice". eLife. 9 (July 28): e55356. doi:10.7554/eLife.55356. PMC   7386913 . PMID   32718435.
  41. Vinueza Veloz MF, Zhou K, Bosman LW, Potters JW, Negrello M, Seepers RM, Strydis C, Koekkoek SK, De Zeeuw CI (2015). "Cerebellar control of gait and interlimb coordination". Brain Struct Funct. 220 (6): 3513–36. doi:10.1007/s00429-014-0870-1. PMC   4575700 . PMID   25139623.
  42. Le Marec N, Lalonde R (1997). "Sensorimotor learning and retention during equilibrium tests in Purkinje cell degeneration mutant mice". Brain Res. 768 (1–2): 310–16. doi:10.1016/s0006-8993(97)00666-5. PMID   9369330. S2CID   7015807.
  43. Le Marec N, Lalonde R (1998). "Treadmill performance of mice with cerebellar lesions: 1. Purkinje cell degeneration mutant mice". Behav Neurosci. 112 (1): 225–232. doi:10.1037/0735-7044.112.1.225. PMID   9517830.
  44. Lalonde R, Manseau M, Botez MI (1989). "Exploration and habituation in Purkinje cell degeneration mutant mice". Brain Res. 479 (1): 201–3. doi:10.1016/0006-8993(89)91354-1. PMID   2924150. S2CID   31202951.
  45. Lalonde R, Manseau M, Botez MI (1987). "Delayed spontaneous alternation in Purkinje cell degeneration mutant mice". Brain Res. 80 (3): 343–6. doi:10.1016/0304-3940(87)90479-4. PMID   3683990. S2CID   23855987.
  46. Lalonde R, Manseau M, Botez MI (1987). "Spontaneous alternation and habituation in Purkinje cell degeneration mutant mice". Brain Res. 411 (1): 343–6. doi:10.1016/0006-8993(87)90699-8. PMID   3607423. S2CID   26705602.
  47. Goodlett CR, Hamre KM, West JR (1992). "Dissociation of spatial navigation and visual guidance performance in Purkinje cell degeneration (pcd) mutant mice". Behav Brain Res. 47 (2): 129–41. doi:10.1016/s0166-4328(05)80119-6. PMID   1590945. S2CID   4061921.
  48. Tuma J, Kolinko Y, Vozeh F, Cendelin J (2015). "Mutation-related differences in exploratory, spatial, and depressive-like behavior in pcd and Lurcher cerebellar mutant mice". Front Behav Neurosci. 12 (9): 116. doi: 10.3389/fnbeh.2015.00116 . PMC   4429248 . PMID   26029065.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.